OrbiMed Advisors III Ltd - Insider Non-Derivative Transactions at Terns Pharmaceuticals, Inc. (TERN) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 16, 2024, OrbiMed Advisors III Ltd's relationship to Terns Pharmaceuticals, Inc. (TERN) is Director,TenPercentOwner, and currently has 4,839,412 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TERN insiders.

Data Source: SEC.
OrbiMed Advisors III Ltd - Insider Non-Derivative Transactions of TERN Common Stock
OrbiMed Advisors III Ltd - Insider Non-Derivative Transactions at TERN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 17, 2024 Sell -- (Common Stock) 623 10 755635
Jul 17, 2024 Sell -- (Common Stock) 556 10 1967924
Jul 17, 2024 Sell -- (Common Stock) 4009 10 4839412
Jul 16, 2024 Sell -- (Common Stock) 6142 10 756258
Jul 16, 2024 Sell -- (Common Stock) 5401 10 1968480
Jul 16, 2024 Sell -- (Common Stock) 39433 10 4843421